Citation Impact
Citing Papers
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
2003
Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated withcis-diamminedichloroplatinum(II)
1990
National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden
2013
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres
2002 StandoutNobel
Relation between dissolution profiles and toxicity of cisplatin-loaded microspheres
2002 StandoutNobel
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat
2005
Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice
2002 StandoutNobel
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Prolonged venous infusion of cisplatin and concurrent radiation therapy for lung carcinoma. A feasibility study
1991
Self-reactive antibodies (natural autoantibodies) in healthy individuals
1998
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
The role of protein translocation in the regulation of glycogen metabolism
2007
Cisplatin Nephrotoxicity: A Review
2007 Standout
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Guideline for hand hygiene in health-care settings
2002 Standout
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
Implementation Research in Mental Health Services: an Emerging Science with Conceptual, Methodological, and Training challenges
2008 Standout
Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
2002 Standout
The Role of Hepatocyte Nuclear Factor-1A in the Pathogenesis of Clear Cell Carcinoma of the Ovary
2009
Progress of drug-loaded polymeric micelles into clinical studies
2014
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
2002
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region
2000 StandoutNobel
Improving Primary Care for Patients With Chronic Illness
2002 Standout
Innate immunity of fish (overview)
2005 Standout
Improving Diabetes Care in a Large Health Care System: An Enhanced Primary Care Approach
2000
Energy Metabolism in the Liver
2014 Standout
Radiotherapy with Concomitant Continuous Cisplatin Infusion for Unresectable Tumors of the Upper Aerodigestive Tract
1997
Endometriosis: pathogenesis and treatment
2013 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo
1997
The energy hypothesis of sleep revisited
2008
Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells
2004
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies*
1998
National Standards for Diabetes Self-Management Education
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
National Standards for Diabetes Self-Management Education
2007
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Palladium-Catalyzed Transformations of Alkyl C–H Bonds
2016 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Randomized Trial of Quality Improvement Intervention to Improve Diabetes Care in Primary Care Settings
2005
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.
1992
About Sleep's Role in Memory
2013 Standout
Does the Chronic Care Model Serve Also as a Template for Improving Prevention?
2001
Glucokinase and molecular aspects of liver glycogen metabolism
2008
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Transition Metal-Catalyzed C–H Amination: Scope, Mechanism, and Applications
2017 Standout
Pharmacokinetic behaviour of cisplatin in peritoneal fluid after intraperitoneal administration of cisplatin-loaded microspheres
2001
Kinetic and Structural Characteristics of the Inhibition of Enoyl (Acyl Carrier Protein) Reductase by Triclosan
1999
Pd-Catalyzed sequential β-C(sp3)–H arylation and intramolecular amination of δ-C(sp2)–H bonds for synthesis of quinolinones via an N,O-bidentate directing group
2016
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of S Freeman being referenced
Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer
1989
TSH Receptor Sequences Recognized by CD4+T Cells in Graves' Disease Patients and Healthy Controls
1995
Using Continuous Quality Improvement to Improve Diabetes Care in Populations: The IDEAL Model
1997
Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations.
1989
An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia
2007
Increased sensitivity of glycogen synthesis to phosphorylase‐a and impaired expression of the glycogen‐targeting protein R6 in hepatocytes from insulin‐resistant Zucker fa/fa rats
2006
Inhibition of squalene synthase of rat liver by novel 3′ substituted quinuclidines
1996
Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine
1996
The Glycogenic Action of Protein Targeting to Glycogen in Hepatocytes Involves Multiple Mechanisms Including Phosphorylase Inactivation and Glycogen Synthase Translocation
2004
Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients
1992
Disposition of unchanged cisplatin in patients with ovarian cancer
1987